NeuroPace, Inc. (NPCE) vs Ovid Therapeutics Inc. (OVID)
A side-by-side comparison of NeuroPace, Inc. and Ovid Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NPCE
NeuroPace, Inc.
$12.77HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
OVID
Ovid Therapeutics Inc.
$2.38HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Total return — NPCE vs OVID
growth of $100 · dividends reinvested · last 5yNPCE -47.0% (-11.9%/yr)OVID -34.8% (-8.2%/yr)OVID compounded faster over this window
NPCE OVID
NPCE vs OVID: by the numbers
- •OVID is the larger company ($443M vs $435M market cap).
- •Both run net losses; NPCE's is the smaller (-19.34% vs -2178.90% net margin).
- •NPCE grew revenue faster over the past five years (15.85% vs -62.76% CAGR).
Metrics side by side
Valuation
| Metric | NPCE | OVID |
|---|---|---|
| P/S ratio | 4.41 | 280.02 |
| P/B ratio | 36.64 | 2.11 |
Profitability
| Metric | NPCE | OVID |
|---|---|---|
| Gross margin | 79.63% | 100.00% |
| Operating margin | -15.26% | -585.20% |
| Net margin | -19.34% | -2178.90% |
| ROE | -160.85% | -16.43% |
| ROIC | -18.95% | -26.29% |
Growth (annualized)
| Metric | NPCE | OVID |
|---|---|---|
| Revenue CAGR (5Y) | 15.85% | -62.76% |
| Total return CAGR (5Y) | -4.94% | -6.98% |
Frequently asked
- Which has grown faster, NPCE or OVID?
- Over the past five years, NPCE grew revenue faster — NPCE at a 15.85% CAGR versus OVID at -62.76%.
- How have NPCE and OVID total returns compared?
- Over the past 5 years, NPCE delivered -4.94% and OVID delivered -6.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
NeuroPace ROEOvid Therapeutics ROENeuroPace operating marginOvid Therapeutics operating marginNeuroPace revenue growthOvid Therapeutics revenue growthNeuroPace free cash flowOvid Therapeutics free cash flow
NeuroPace & Ovid Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.